TY - JOUR AU - Kovács, Adrienn Nikolett AU - Bunduc, Stefania AU - Veres, Dániel AU - Pálinkás, Dániel AU - Gagyi , Endre AU - Hegyi, Péter Jenő AU - Erőss, Bálint Mihály AU - Mihály, Emese AU - Hegyi, Péter AU - Hosszúfalusi, Nóra TI - One third of cases of new-onset diabetic ketosis in adults are associated with ketosis-prone type 2 diabetes-A systematic review and meta-analysis JF - DIABETES-METABOLISM RESEARCH AND REVIEWS J2 - DIABETES-METAB RES VL - 40 PY - 2024 IS - 3 PG - 10 SN - 1520-7552 DO - 10.1002/dmrr.3743 UR - https://m2.mtmt.hu/api/publication/34227657 ID - 34227657 AB - Ketosis-prone type 2 diabetes was defined by the World Health Organization in 2019. According to the literature, the diagnosis is based on the presence of ketosis, islet autoantibody negativity and preserved insulin secretion. Our meta-analysis assessed the prevalence and clinical characteristics of ketosis-prone type 2 diabetes among patients hospitalised with diabetic ketoacidosis (DKA) or ketosis.The systematic search was performed in five main databases as of 15 October 2021 without restrictions. We calculated the pooled prevalence of ketosis-prone type 2 diabetes (exposed group) within the diabetic population under examination, patients with ketoacidosis or ketosis, to identify the clinical characteristics, and we compared it to type 1 diabetes (the comparator group). The random effects model provided pooled estimates as prevalence, odds ratio and mean difference (MD) with 95% confidence intervals.Eleven articles were eligible for meta-analysis, thus incorporating 2010 patients of various ethnic backgrounds. Among patients presenting with DKA or ketosis at the onset of diabetes, 35% (95% CI: 24%-49%) had ketosis-prone type 2 diabetes. These patients were older (MD = 11.55 years; 95% CI: 5.5-17.6) and had a significantly higher body mass index (BMI) (MD = 5.48 kg/m2 ; 95% CI: 3.25-7.72) than those with type 1 diabetes.Ketosis-prone type 2 diabetes accounts for one third of DKA or ketosis at the onset of diabetes in adults. These patients are characterised by islet autoantibody negativity and preserved insulin secretion. They are older and have a higher BMI compared with type 1 diabetes. C-peptide and diabetes-related autoantibody measurement is essential to identify this subgroup among patients with ketosis at the onset of diabetes. LA - English DB - MTMT ER - TY - JOUR AU - Kovács, A AU - Hosszúfalusi, Nóra AU - Lukács, Krisztina AU - Sipter, Emese AU - Teutsch, Brigitta AU - Veres, Dániel AU - Hegyi, Péter AU - Pánczél, Pál TI - A DIABETESHEZ KAPCSOLT AUTOANTITEST ÉS A C-PEPTID MEGHATÁROZÁS JELENTŐSÉGE FELNŐTTKORBAN, KETÓZISSAL INDULÓ CUKORBETEGSÉGBEN: PROSPEKTÍV VIZSGÁLAT JF - MAGYAR BELORVOSI ARCHIVUM J2 - MBA VL - 76 PY - 2023 IS - 5-6 SP - 318 EP - 319 PG - 2 SN - 0133-5464 UR - https://m2.mtmt.hu/api/publication/34565192 ID - 34565192 LA - Hungarian DB - MTMT ER - TY - JOUR AU - Zahariev, Julia Olga AU - Bunduc, Stefania AU - Kovács, Adrienn Nikolett AU - Demeter, Dóra AU - Havelda, Luca AU - Budai, Bettina Csilla AU - Veres, Dániel AU - Hosszúfalusi, Nóra AU - Erőss, Bálint Mihály AU - Teutsch, Brigitta AU - Juhász, Márk Félix AU - Hegyi, Péter TI - Risk factors for diabetes mellitus after acute pancreatitis : a systematic review and meta-analysis JF - FRONTIERS IN MEDICINE J2 - FRONT MED VL - 10 PY - 2023 PG - 18 SN - 2296-858X DO - 10.3389/fmed.2023.1257222 UR - https://m2.mtmt.hu/api/publication/34536097 ID - 34536097 N1 - * Megosztott szerzőség AB - Within 5 years of having acute pancreatitis (AP), approximately 20% of patients develop diabetes mellitus (DM), which later increases to approximately 40%. Some studies suggest that the prevalence of prediabetes (PD) and/or DM can grow as high as 59% over time. However, information on risk factors is limited. We aimed to identify risk factors for developing PD or DM following AP.We systematically searched three databases up to 4 September 2023 extracting direct, within-study comparisons of risk factors on the rate of new-onset PD and DM in AP patients. When PD and DM event rates could not be separated, we reported results for this composite outcome as PD/DM. Meta-analysis was performed using the random-effects model to calculate pooled odds ratios (OR) with 95% confidence intervals (CI).Of the 61 studies identified, 50 were included in the meta-analysis, covering 76,797 participants. The studies reported on 79 risk factors, and meta-analysis was feasible for 34 risk factor and outcome pairs. The odds of developing PD/DM was significantly higher after severe and moderately severe AP (OR: 4.32; CI: 1.76-10.60) than mild AP. Hypertriglyceridemic AP etiology (OR: 3.27; CI: 0.17-63.91) and pancreatic necrosis (OR: 5.53; CI: 1.59-19.21) were associated with a higher risk of developing PD/DM. Alcoholic AP etiology (OR: 1.82; CI: 1.09-3.04), organ failure (OR: 3.19; CI: 0.55-18.64), recurrent AP (OR: 1.89; CI: 0.95-3.77), obesity (OR: 1.85; CI: 1.43-2.38), chronic kidney disease (OR: 2.10; CI: 1.85-2.38), liver cirrhosis (OR: 2.48; CI: 0.18-34.25), and dyslipidemia (OR: 1.82; CI: 0.68-4.84) were associated with a higher risk of developing DM.Severe and moderately severe AP, alcoholic and hypertriglyceridemic etiologies, pancreatic necrosis, organ failure, recurrent acute pancreatitis and comorbidities of obesity, chronic kidney disease liver disease, and dyslipidemia are associated with a higher risk of developing PD or DM.https://www.crd.york.ac.uk/prospero/, identifier CRD42021281983. LA - English DB - MTMT ER - TY - JOUR AU - Obeidat, Mahmoud Mohammadnour Suleiman AU - Teutsch, Brigitta AU - Rancz, Anett AU - Tari, Edina AU - Márta, Katalin AU - Veres, Dániel AU - Hosszúfalusi, Nóra AU - Mihály, Emese AU - Hegyi, Péter AU - Erőss, Bálint Mihály TI - One in four patients with gastrointestinal bleeding develops shock or hemodynamic instability : A systematic review and meta-analysis JF - WORLD JOURNAL OF GASTROENTEROLOGY J2 - WORLD J LGASTROENTEROL VL - 29 PY - 2023 IS - 28 SP - 4466 EP - 4480 PG - 15 SN - 1007-9327 DO - 10.3748/wjg.v29.i28.4466 UR - https://m2.mtmt.hu/api/publication/34103678 ID - 34103678 AB - Hemodynamic instability and shock are associated with untoward outcomes in gastrointestinal bleeding. However, there are no studies in the existing literature on the proportion of patients who developed these outcomes after gastrointestinal bleeding.To determine the pooled event rates in the available literature and specify them based on the bleeding source.The protocol was registered on PROSPERO in advance (CRD42021283258). A systematic search was performed in three databases (PubMed, EMBASE, and CENTRAL) on 14th October 2021. Pooled proportions with 95%CI were calculated with a random-effects model. A subgroup analysis was carried out based on the time of assessment (on admission or during hospital stay). Heterogeneity was assessed by Higgins and Thompson's I2 statistics. The Joanna Briggs Institute Prevalence Critical Appraisal Tool was used for the risk of bias assessment. The Reference Citation Analysis (https://www.referencecitationanalysis.com/) tool was applied to obtain the latest highlight articles.We identified 11589 records, of which 220 studies were eligible for data extraction. The overall proportion of shock and hemodynamic instability in general gastrointestinal bleeding patients was 0.25 (95%CI: 0.17-0.36, I2 = 100%). In non-variceal bleeding, the proportion was 0.22 (95%CI: 0.14-0.31, I2 = 100%), whereas it was 0.25 (95%CI: 0.19-0.32, I2 = 100%) in variceal bleeding. The proportion of patients with colonic diverticular bleeding who developed shock or hemodynamic instability was 0.12 (95%CI: 0.06-0.22, I2 = 90%). The risk of bias was low, and heterogeneity was high in all analyses.One in five, one in four, and one in eight patients develops shock or hemodynamic instability on admission or during hospitalization in the case of non-variceal, variceal, and colonic diverticular bleeding, respectively. LA - English DB - MTMT ER - TY - JOUR AU - Rancz, Anett AU - Teutsch, Brigitta AU - Engh, Marie Anne AU - Veres, Dániel AU - Földvári-Nagy, László AU - Erőss, Bálint Mihály AU - Hosszúfalusi, Nóra AU - Juhász, Márk Félix AU - Hegyi, Péter AU - Mihály, Emese TI - Microscopic colitis is a risk factor for low bone density: a systematic review and meta-analysis JF - THERAPEUTIC ADVANCES IN GASTROENTEROLOGY J2 - THER ADV GASTROENTER VL - 16 PY - 2023 PG - 13 SN - 1756-283X DO - 10.1177/17562848231177151 UR - https://m2.mtmt.hu/api/publication/34039131 ID - 34039131 N1 - Centre for Translational Medicine, Semmelweis University, Budapest, Hungary Department of Internal Medicine and Hematology, Medical School, Semmelweis University, Budapest, Hungary Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary Heim Pál National Pediatric Institute, Budapest, Hungary Export Date: 16 October 2023 Correspondence Address: Mihály, E.email: emesemihaly@hotmail.com Funding text 1: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This project was supported by an ITM NRDIF grant (TKP2021-EGA-23). AB - Background:Microscopic colitis (MC) is a chronic inflammatory disease of the large bowel characterized by watery diarrhea, substantially decreasing the patient's quality of life. Scarce data suggest that MC is associated with low bone density (LBD). Objectives:We aimed to assess whether MC is a risk factor for LBD and the proportion of patients with MC having LBD. Design:A systematic review and meta-analysis of studies reporting bone density measurements in MC patients. Data Sources and Methods:We systematically searched five databases from inception to October 16, 2021 (Pubmed, Embase, Cochrane, Scopus, and Web of Science). We used the random-effect model to calculate pooled odds ratios (ORs) and pooled event rates with 95% confidence intervals (CIs). To ascertain the quality of evidence of our outcomes, we followed the recommendations of the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Working Group. Results:The systematic search yielded a total of 3046 articles. Four articles were eligible for quantitative synthesis. All of them used age- and sex-matched controls to evaluate LBD occurrence among patients with MC. The odds of having LBD were twofold increased (OR = 2.13, CI: 1.42-3.20) in the presence of MC, the odds of osteopenia occurrence were 2.4 (OR = 2.45, CI: 1.11-5.41), and of osteoporosis 1.4 (OR = 1.42, CI: 0.65-3.12). The proportion of LBD was 0.68 (CI: 0.56-0.78), osteopenia was 0.51 (CI: 0.43-0.58), and osteoporosis was 0.11 (CI: 0.07-0.16) among the MC population. Our findings' certainty of the evidence was very low following the GRADEPro guideline. Conclusion:Our data demonstrate that MC is associated with a twofold risk for LBD. Based on our findings, we suggest screening patients for bone mineral density upon diagnosis of MC. Further prospective studies with higher patient numbers and longer follow-up periods on this topic are needed. Registration:Our protocol was prospectively registered with PROSPERO (CRD42021283392). Plain language summaryInvestigating microscopic colitis as a risk factor for having low bone density in a literature overview and statistical approachMicroscopic colitis (MC) is an underdiagnosed chronic inflammatory large bowel disease, characterized by watery diarrhea, which substantially impacts the patient's quality of life. The etiology of MC is still unclear but is suspected to be multifactorial. Moreover, low bone density (LBD) has been associated with the disease. Scarce data investigate the relationship of MC with LBD, although they share common risk factors, like advanced age and female sex. LBD has two forms; the mild is osteopenia and the severe form is osteoporosis. The most severe complications of osteoporosis are osteoporotic fractures, which can culminate in a life-threatening state and amplify the hospital expenses burden.Our primary aim was to assess if MC increases the risk of LBD. Furthermore, we estimated the proportions of bone mineral changes in the MC population.Following a rigorous methodology, our data suggest that MC doubles the odds of LBD. Furthermore, we have shown that two-thirds of the MC population suffers from bone density decrease, half of them have osteopenia, and one in 10 MC patients has osteoporosis.In conclusion, we highly suggest screening patients with MC for bone mineral density at the moment of diagnosis. LA - English DB - MTMT ER - TY - JOUR AU - Pálinkás, Dániel AU - Teutsch, Brigitta AU - Gagyi , Endre AU - Engh, Marie Anne AU - Kalló, Patrícia AU - Veres, Dániel AU - Földvári-Nagy, László AU - Hosszúfalusi, Nóra AU - Hegyi, Péter AU - Erőss, Bálint Mihály TI - No Association between Gastrointestinal Rebleeding and DOAC Therapy Resumption : A Systematic Review and Meta-Analysis JF - BIOMEDICINES J2 - BIOMEDICINES VL - 11 PY - 2023 IS - 2 PG - 14 SN - 2227-9059 DO - 10.3390/biomedicines11020554 UR - https://m2.mtmt.hu/api/publication/33667130 ID - 33667130 N1 - Funding Agency and Grant Number: ITM NRDIF grant [TKP2021-EGA-23] Funding text: The project was supported by an ITM NRDIF grant (TKP2021-EGA-23). Funders had no role in the design, data collection, analysis, interpretation, manuscript preparations, or the decision to submit the manuscript for publication. AB - There are recommendations for anticoagulation resumption after gastrointestinal bleeding (GIB), although data addressing this topic by direct oral anticoagulants (DOACs)-treated patients is lacking. We aim to determine the safety and efficacy of restarting DOACs after GIB.Studies that reported rebleeding, thromboembolic events, and mortality after restarting or withholding DOACs were selected. The systematic research was conducted in five databases (MEDLINE, EMBASE, CENTRAL, Web of Science, and Scopus). The random effect model was implemented to calculate the pooled odds ratio (OR). The ROBINS-I tool was used for risk of bias assessment, and the certainty of the evidence was evaluated with the GRADE approach.Four retrospective cohort studies (1722 patients) were included in the meta-analysis. We did not find a significant increase in the risk of rebleeding in patients restarting DOACs after index GIB (OR = 1.12; 95% CI: 0.74-1.68). The outcomes of thromboembolic events and mortality data were not suitable for meta-analytic calculations. Single studies did not show statistically significant differences. Data quality assessment showed a serious overall risk of bias and very low quality of evidence (GRADE D).DOAC resumption after a GIB episode may not elevate the risk of rebleeding. However, the need for high-quality randomized clinical trials is crucial. LA - English DB - MTMT ER - TY - JOUR AU - Kovacs, A. AU - Bunduc, S. AU - Veres, D. S. AU - Palinkas, D. AU - Gagyi, E. B. AU - Marta, K. AU - Hegyi, J. P. AU - Eross, B. AU - Mihály, Emese AU - Sipter, Emese AU - Pánczél, Pál AU - Hegyi, P. AU - Hosszúfalusi, Nóra TI - About one-in-three new onset diabetic ketosis cases is caused by ketosis-prone type 2 diabetes in adults: a systematic review and meta-analysis JF - DIABETOLOGIA J2 - DIABETOLOGIA VL - 65 PY - 2022 IS - SUPPL 1 SP - S176 EP - S177 PG - 2 SN - 0012-186X UR - https://m2.mtmt.hu/api/publication/34802732 ID - 34802732 N1 - Supplement: 1 LA - English DB - MTMT ER - TY - JOUR AU - Ambrus, Viktória AU - Vida, Ádám AU - Somogyi, Anikó AU - Sármán, Beatrix AU - Nagy, Géza AU - Herold, Magdolna AU - Hosszúfalusi, Nóra AU - Sipter, Emese TI - KARDIOVASZKULÁRIS KOCKÁZAT KORAI KEZDETŰ ÉS HOSSZÚ BETEGSÉGTARTAMÚ 1-ES TÍPUSÚ CUKORBETEGSÉGBEN: NAGY RIZIKÓ – KEVÉS FIGYELEM JF - DIABETOLOGIA HUNGARICA J2 - DIABETOLOGIA HUNGARICA VL - XXX. PY - 2022 IS - 2 Suppl. SP - 6 EP - 6 PG - 1 SN - 1217-372X UR - https://m2.mtmt.hu/api/publication/34138718 ID - 34138718 N1 - előadás LA - Hungarian DB - MTMT ER - TY - JOUR AU - Palinkas, D AU - Teutsch, B AU - Gagyi , Endre AU - Engh, MA AU - Veres, DS AU - Hosszúfalusi, Nóra AU - Herszényi, L AU - Hegyi, P AU - Erőss, B TI - The safety and efficacy of direct oral anticagulant resumption following a gastrointestinal bleeding episode: a systematic review and meta-analysis JF - UNITED EUROPEAN GASTROENTEROLOGY JOURNAL J2 - UEG JOURNAL VL - 10 PY - 2022 IS - S8 SP - 481 EP - 482 PG - 2 SN - 2050-6406 UR - https://m2.mtmt.hu/api/publication/34080912 ID - 34080912 N1 - UEG Week 2022 Poster Presentations LA - English DB - MTMT ER - TY - JOUR AU - Rácz, Olivér AU - Barkai, László József AU - Salamonová, Blichová Lenka AU - Sipter, Emese AU - Hosszúfalusi, Nóra TI - Az 1,5-anhidroglucitol és az anyagcserekontroll többi mutatója közötti összefüggés vizsgálata diabetes mellitusban JF - DIABETOLOGIA HUNGARICA J2 - DIABETOLOGIA HUNGARICA VL - 30 PY - 2022 IS - S2 SP - 86 EP - 87 PG - 2 SN - 1217-372X UR - https://m2.mtmt.hu/api/publication/34022784 ID - 34022784 LA - Hungarian DB - MTMT ER -